Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02022371
What this trial is testing

Prostate Cancer Genomic Heterogeneity

Who this might be right for
PROSTATE CANCER
University College London Hospitals 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49
Not applicableWithdrawnNCT00801996
What this trial is testing

Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT01795703
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 47
Not applicableActive Not RecruitingNCT06051942
What this trial is testing

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Who this might be right for
Benign Prostatic HyperplasiaLocalized Prostate Cancer
PROCEPT BioRobotics 125
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Testing effectiveness (Phase 2)Study completedNCT03396874
What this trial is testing

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Metastatic+1 more
University of Michigan 1,435
Large-scale testing (Phase 3)UnknownNCT02668718
What this trial is testing

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Helsinki University Central Hospital 250
Early research (Phase 1)Study completedNCT00748046
What this trial is testing

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Who this might be right for
Prostate CancerMetastasesPharmacokinetics
Bayer 10
Not applicableUnknownNCT01764646
What this trial is testing

Hypofractionated Radiation Therapy in Prostate Cancer

Who this might be right for
Malignant Neoplasm of ProstateLocal Disease
Thomas Zilli 170
Not applicableStudy completedNCT02479945
What this trial is testing

Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)Study completedNCT03199872
What this trial is testing

RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours

Who this might be right for
Prostate Cancer
RhoVac APS 22
Early research (Phase 1)Looking for participantsNCT07514065
What this trial is testing

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd 78
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Early research (Phase 1)Study completedNCT06559007
What this trial is testing

Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants

Who this might be right for
Prostate Cancer
Atridia Pty Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00982800
What this trial is testing

Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy?

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Testing effectiveness (Phase 2)Study completedNCT00002637
What this trial is testing

Biological Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00076531
What this trial is testing

Clinical Trial for Prostate Cancer

Who this might be right for
Prostate Cancer
Oakwood Laboratories, LLC
Testing effectiveness (Phase 2)Study completedNCT02203695
What this trial is testing

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Next Page